CRISPR twins: a condemnation from Chinese academic societies

Haoyi Wang,Jinsong Li,Wei Li,Caixia Gao,Wensheng Wei

DOI: https://doi.org/10.1038/d41586-018-07777-0

IF: 64.8

2018-01-01

Nature

Abstract:Discover the world’s best science and medicine | Nature.com

What problem does this paper attempt to address?

Comments on the CRISPR Gene-edited Babies’ Case

Yali Cong

DOI: https://doi.org/10.20529/ijme.2019.039

2019-01-01

Abstract:Twin girls were born in China in November 2018 to an HIV-positive father and an HIV-negative mother, through in vitro fertilisation in combination with CRISPR-Cas9 genome editing which altered their CCR5 genes. An investigation found that regulations were broken, and documents were forged. The government needs to address various regulatory defects, improve oversight of research, and implement institutional policies on conflict of interest.
Trio deep-sequencing does not reveal unexpected mutations in Cas9-edited monkeys

Xin Luo,Yaoxi He,Chao Zhang,Xiechao He,Lanzhen Yan,Min Li,Ting Hu,Yan Hu,Jin Jiang,Xiaoyu Meng,Weizhi Ji,Xudong Zhao,Ping Zheng,Shuhua Xu,Bing Su

DOI: https://doi.org/10.1101/339143

2018-01-01

bioRxiv

Abstract:CRISPR-Cas9 is a widely-used genome editing tool, but its off-target effect remains a concern, especially in view of future clinical applications. Non-human primates (NHPs) share close genetic and physiological similarities with humans, making them an ideal preclinical model for developing Cas9-based therapies. However, no comprehensive in vivo off-target assessment has been conducted in NHPs. Here we performed whole genome trio sequencing of Cas9-treated monkeys. We found they only carried a small number of de novo mutations that can be explained by expected spontaneous mutations, and no unexpected mutations were detected.
Breaking the germline barrier in a moral vacuum

Sheldon Krimsky

DOI: https://doi.org/10.1080/08989621.2019.1644171

Abstract:In November 2018 a Chinese scientist claimed to have used CRISPR/Cas 9 technology to genetically modify two human embryos that were then gestated in one adult woman through an IVF pregnancy and brought to term. The twin girls are allegedly the first babies born with their prenatal genomes edited. Using both English language and Chinese supporting documents, this paper discusses the background of this human experiment, the social context of Chinese science, and the alleged ethical transgressions of its principal scientist.
The CRISPR-baby scandal: what’s next for human gene-editing

David Cyranoski

DOI: https://doi.org/10.1038/d41586-019-00673-1

IF: 64.8

2019-02-01

Nature

Abstract:As concerns surge after a bombshell revelation, here are four questions about this fast-moving field.

multidisciplinary sciences
CCR5-Δ32 biology, gene editing, and warnings for the future of CRISPR-Cas9 as a human and humane gene editing tool

MengMeng Xu

DOI: https://doi.org/10.1186/s13578-020-00410-6

2020-03-30

Abstract:Background: Biomedical technologies have not just improved human health but also assisted in the creation of human life. Since the first birth of a healthy baby by in vitro fertilization (IVF) 40 years ago, IVF has been the mainstay treatment for couples struggling with infertility. This technology, in addition to increasingly accessible genetic testing, has made it possible for countless couples to have children. Since CRISPR-Cas9 gene editing was described in 2015, its potential for targeting genetic diseases has been much anticipated. However, the potential of using CRISPR-Cas9 for human germline modification has led to many fears of "designer babies" and widespread concerns for the impact of this technology on human evolution and its implications in Social Darwinism. In addition to these ethical/moral concerns, there remain many unknowns about CRISPR-Cas9 technology and endless unanticipated consequence to gene editing. Methods: In this paper, we analyze the current progresses of CRISPR-Cas9 technology and discuss the theoretical advantages of certain allelic variances in the C-C chemokine receptor 5 gene (CCR5) in the setting of recent ethical/moral concerns regarding gene editing using the CRISPR-Cas9 system. Results: These uncertainties have been highlighted recently by the birth of Chinese twins whose C-C chemokine receptor 5 (CCR5) gene had been inactivated via CRISPR-Cas9 to be theoretically protective against HIV infection. CCR5 signaling is critical for the successful infection of human immunodeficiency virus (HIV) and people with homozygous inactivating CCR5-Δ32 mutations have been shown to be protected against HIV infection. Those with the CCR5-Δ32/Δ32 mutation also have greater neuroplasticity, allowing for improved recovery from neurological trauma, and decreased Chagas cardiomyopathy. However, the CCR5-Δ32/Δ32 mutation has also been associated with earlier clinical manifestations for West Nile infection, ambiguous effects on osteoclast function, and a four-fold increased mortality from influenza infection. These detrimental health impacts, in addition to the confounding factor that these CRISPR babies do not carry this exact CCR5-Δ32/Δ32 mutation, lead to many questions regarding the children's future health and the moral conundrum of their birth. The creation and birth of these babies was not completed with any scientific, ethical, or governmental oversight, which has spurned the acceleration of talks regarding global regulations for human genetic editing. Conclusions: Although we can try to regulate for ethical, health-related only use of this technology, moral and governmental oversights need to be supplemented by technical regulations. For instance, whole genome sequencing needs to be used to eliminate off-target mutations that could affect the health and safety of infants born to this process. Like Pandora's Box, we cannot pretend to forget CRISPR-Cas9 technology, all we can do is ensure a safe, moral, and equitable used of this technology.
Conflict of Interest in Scientific Research in China: A Socio-ethical Analysis of He Jiankui’s Human Genome-editing Experiment

Nie Jing-Bao,Xie Guangkuan,Chen Hua,Cong Yali

DOI: https://doi.org/10.1007/s11673-020-09978-7

2020-01-01

Journal of Bioethical Inquiry

Abstract:Extensive conflicts of interest (COI) at both individual and institutional levels are identifiable in scientific research and healthcare in China, as in many other parts of the world. A prominent new case from China is He Jiankui’s experiment that produced the world’s first gene-edited babies and that raises numerous ethical, political, socio-cultural, and transnational questions. Serious financial and other COI were involved in He’s genetic adventure. Using He’s infamous experiment as a case study, this paper explores the wider issue of financial and other COI in scientific research and healthcare in China, especially institutional conflict of interest (ICOI) and policy-related COI. Taking a socio-ethical perspective, it examines China’s state policies and its massive efforts to transform and commercialize scientific research, the lack of policies and oversight mechanisms for regulating COI, as well as major ethical issues arising from COI including the undermining of public trust. Some practical suggestions are offered for institutional reform and institutional development so that COI, particularly ICOI, can be avoided or more effectively managed in scientific research in China.
The CRISPR animal kingdom.

Jon Cohen

DOI: https://doi.org/10.1126/science.365.6452.426

IF: 56.9

2019-08-02

Science

Abstract:China has racked up a long list of firsts when it comes to using the genome editor CRISPR in different animal species: mice, rats, rabbits, dogs, pigs, and monkeys. With substantial investments from the government, researchers are rapidly producing new monkey models to study diseases that afflict humans as well as improvements in livestock that can stave off pig disease or create tastier meats. Genetic manipulations of pigs are also attempting to make their organs more humanlike so they can be transplanted into people without causing immune rejection. And all of this work is taking place against a cultural backdrop that, in contrast to the United States and Europe, has shown little strong opposition to animal research. But CRISPR modification of animals is still in its infancy, and tangible advances that benefit humans remain in the distant future.

Medicine,Biology
Debating Ethical Issues in Genome Editing Technology

R. Qiu

DOI: https://doi.org/10.1353/ASB.2016.0026

2016-12-29

Abstract:This paper provides an ethical analysis of the controversy that arose from the CRISPR/Cas9 gene editing research involving human embryos that was conducted by a research team in Guangzhou, China, in 2015. It is argued that the researchers involved did not overstep ethical boundaries. This was confirmed to be the case in an international meeting of experts that was convened following the controversy. It is further argued that the controversy highlights the tension between two fundamentally different policies on developing genome editing technology – one proactionary and the other precautionary. This paper argues for a third approach, based on the policy of “crossing the river by probing stones”. Such an approach is consistent with current international recommendations to prioritise basic and pre-clinical research, and to allow the application of genome editing technology to somatic human cells. However, the application of the technology in germline genetic modification for human reproduction or enhancement for medical purposes should not be allowed at present. This is because the attending risks are not well understood and could be excessive or extraordinary, with little or no prospect of benefit. In addition, this paper calls for norms and regulations to be developed for genetically modifying non-human living things. Finally, the paper concludes with a letter that was sent by the author (and another) to the New York Times, setting out China’s fundamental stance on genetic modification involving humans and human derivatives.

Biology,Sociology,Philosophy,Medicine
[The Chinese National Twin Cohort: an Update].

W J Gao,L M Li

DOI: https://doi.org/10.3760/cma.j.issn.0254-6450.2017.06.027

2017-01-01

Abstract:The importance of large cohort studies in China has been increasingly emphasized. As special group in the population, twins provide excellent natural resources since they share the same birthday, maternal intrauterine environment and early family environment. Twin cohorts are unique for and benefit on controlling the confounding factors as age, gender (same-sex twins), genetic background (monozygotic twins) or early environment (being raised together) in the etiological studies on complex diseases. In this review, we briefly introduce the objectives, current situation, challenges and opportunities related to the Chinese national twin cohort, focusing on the characteristics of twins that are different from other groups in the general population.
Discovery in CRISPR-Cas9 system.

Huali Zhang,Shaowei Pan

DOI: https://doi.org/10.11817/j.issn.1672-7347.2021.210169

2021-12-28

Abstract:The 2020 Nobel Prize in Chemistry was awarded to the American scientist Jennifer A. Doudna and the French scientist Emmanuelle Charpentier, in recognition of their discovery in one of the greatest weapons in genetic technology: CRISPR-Cas9 gene scissors. The CRISPR-Cas system is a bacterial defense immune system against exogenous genetic material. Because the system can specifically recognize and cut DNA, this technology is widely used for precise editing of animal, plant, and microbial DNA. The discovery of CRISPR-Cas9 gene scissors enables the tedious and complicated cell gene editing work to be completed in a few weeks or even less, which has promoted the development of gene editing technology in various fields and brought revolutionary influence to the field of life sciences. At the same time, CRISPR gene editing technology has become one of the new therapies for tumors because of its large number of targets and relatively simple operation, and it also makes gene therapy possible. Although the technology still needs to solve technical problems such as off-target and promoter inefficiency, the CRISPR-Cas system will show its unique advantages in more fields with the continuous development of life science and basic medicine.

Medicine,Chemistry
Development and application of CRISPR/Cas9 technologies in genomic editing.

Cui Zhang,Renfu Quan,Jinfu Wang

DOI: https://doi.org/10.1093/hmg/ddy120

IF: 5.1214

2018-01-01

Human Molecular Genetics

Abstract:Genomic editing to correct disease-causing mutations is a promising approach for the treatment of human diseases. As a simple and programmable nuclease-based genomic editing tool, the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) system has substantially improved the ability to make precise changes in the human genome. Rapid development of CRISPR-based technologies in recent years has expanded its application scope and promoted CRISPR-based therapies in preclinical trails. Here, we review the application of the CRISPR system over the last 2 years; including its development and application in base editing, transcription modulation and epigenetic editing, genomic-scale screening, and cell and embryo therapy. Finally, the prospects and challenges related to application of CRISPR/Cas9 technologies are discussed.
Impact of Chromatin Organization and Epigenetics on CRISPR-Cas and TALEN Genome Editing

Surbhi Jain,Guanhua Xun,Huimin Zhao

DOI: https://doi.org/10.1021/acssynbio.4c00099

IF: 5.249

2024-09-25

ACS Synthetic Biology

Abstract:DNA lies at the heart of the central dogma of life. Altering DNA can modify the flow of information in fundamental cellular processes such as transcription and translation. The ability to precisely manipulate DNA has led to remarkable advances in treating incurable human genetic ailments and has changed the landscape of biological research. Genome editors such as CRISPR-Cas nucleases and TALENs have become ubiquitous tools in basic and applied biological research and have been translated to the...

biochemical research methods
The Chinese National Twin Registry: a ‘gold Mine’ for Scientific Research

Wenjing Gao,Weihua Cao,Jun Lv,Yu Chen,Tao Wu,S Wang,Lu Meng,D Wang,Z Wang,Zengchang Pang,Min Yu,H Wang,Xuesong Wu,Dong Zhao,Fan Wu,Guohong Jiang,X Wang,Y Liu,Jing Deng,Lin Lü,L Li

DOI: https://doi.org/10.1111/joim.12926

2019-01-01

Journal of Internal Medicine

Abstract:The Chinese National Twin Registry (CNTR) currently includes data from 61 566 twin pair from 11 provinces or cities in China. Of these, 31 705, 15 060 and 13 531 pairs are monozygotic, same‐sex dizygotic and opposite‐sex dizygotic pairs, respectively, determined by opposite sex or intrapair similarity. Since its establishment in 2001, the CNTR has provided an important resource for analysing genetic and environmental influences on chronic diseases especially cardiovascular diseases. Recently, the CNTR has focused on collecting biologic specimens from disease‐concordant or disease‐discordant twin pairs or from twin pairs reared apart. More than 8000 pairs of these twins have been registered, and blood samples have been collected from more than 1500 pairs. In this review, we summarize the main findings from univariate and multivariate genetic effects analyses, gene–environment interaction studies, omics studies exploring DNA methylation and metabolomic markers associated with phenotypes. There remains further scope for CNTR research and data mining. The plan for future development of the CNTR is described. The CNTR welcomes worldwide collaboration.
The application and development of CRISPR Cas9

Jingyi Wang

DOI: https://doi.org/10.54097/ecydqr13

2024-07-11

Abstract:This comprehensive review paper thoroughly explores the developmental background, basic principles, application examples, and the current challenges and ethical issues associated with CRISPR-Cas9 technology, and provides an in-depth forecast and outlook on its future directions. Originating from a natural immune mechanism in bacteria, CRISPR-Cas9 technology can precisely identify and cut targeted DNA sequences to achieve gene editing. Characterized by its ease of operation, low cost, and high efficiency, it has been widely applied in biological research, medical treatment, agricultural improvement, and other areas, bringing an unprecedented ability to transform life. This paper extensively introduces various application examples of CRISPR-Cas9 technology, including but not limited to the study of gene functions, treatment of genetic diseases, development of antiviral therapies, and enhancement of crop traits. These applications showcase the enormous potential of CRISPR-Cas9 technology in driving scientific advancement and solving practical problems. However, with the widespread application of the technology, a series of challenges and ethical concerns have arisen. The paper delves into issues such as potential off-target effects of gene editing, ecological risks associated with gene drives, and the ethical boundaries of human embryonic gene editing. The paper anticipates the future development of CRISPR-Cas9, suggesting that with a deeper understanding and continuous refinement of the technology, it may play an even greater role in precision medicine, biopharmaceuticals, bioenergy, and other fields [1].
Unexpected CRISPR off-target mutation pattern in vivo are not typically germline-like

Zhiting Wei,Funan He,Guohui Chuai,Hanhui Ma,Zhixi Su,Qi Liu

DOI: https://doi.org/10.1101/193565

2017-01-01

bioRxiv

Abstract:A computationally evolutionary investigation was performed to re-analyze the WGS data of the two studies published in Nature Methods (2015, 2017) with opposite conclusions on CRISPR off-target mutations. Our analysis concluded that the so-called unexpected SNVs pattern obtained by the study of Schaefer et al. are not typically germline-like. Some of unusual and unidentified mutations may arise, but the real reasons remain to be explored. Based on the available data and a direct comparison of the two studies, we presented two possible reasons and future re-analysis directions that may contribute to such different conclusions. To characterize the authentic CRISPR-mediated mutations, we are required to have appropriate controls to rule out other sources of mutations, which will be needed for benchmarking of targeting safety of CRISPR-based gene therapy.
One-step homozygosity in precise gene editing by an improved CRISPR/Cas9 system

Pei Zhao,Zhe Zhang,Xiaoying Lv,Xiang Zhao,Yuji Suehiro,Yinan Jiang,Xinquan Wang,Shohei Mitani,Haipeng Gong,Ding Xue

DOI: https://doi.org/10.1038/cr.2016.46

IF: 44.1

2016-01-01

Cell Research

Abstract:The CRISPR/Cas9 gene editing method has been successfully applied to modify genomes in many organisms1. However, several critical issues remain unresolved and have become major hurdles for its broad applications1.
Recent Developments in the Regulation of Heritable Human Genome Editing

S Soni

DOI: https://doi.org/10.1007/s11673-023-10332-w

Abstract:In 2018, the Chinese scientist He Jiankui presented his research at the Second International Summit on Human Genome Editing in Hong Kong. While it was intended that he facilitate a workshop, he was instead called on to present his research in heritable human genome editing, where he made the announcement that he had taken great strides in advancement of his research, to the extent that he had gene-edited human embryos and that this had resulted in the live births of two children. While his research ethic and methodology was interrogated, he insisted that two children, twin girls, had been born healthy and that there was another pregnancy (at the time) where birth of a third gene edited child would be imminent. This announcement generated a ripple effect in the scientific community and exposed the gaps in regulation and absence of law relating to the technology. This resulted in a flurry of activity and conversation around regulation of the technology, which scientists stated was not ready for human trials. This article reviews the Third Summit which was held in London in March 2023 and comments on the latest developments in the regulation of heritable human genome editing.
Before and after the Chinese gene-edited human babies: Multiple discourses of gene editing on social media

Xing Zhang,Anfan Chen,Weiyu Zhang

DOI: https://doi.org/10.1177/0963662520987754

2021-01-19

Public Understanding of Science

Abstract:This study examines discourses in Chinese online discussions of gene editing by multiple social actors on Weibo before and after a significant scientific crisis, the 2018 scandal of Chinese gene-edited human babies. A content analysis of 2074 posts was done to identify frames, emotions, and metaphors. Findings reveal that Chinese social media have opened up new spaces for multiple social actors to generate multiple discourses. This has resulted in a more participatory public engagement with science and technology on Chinese social media, potentially influencing the online agenda and policy decisions on science and technology. Finally, findings indicate that a scientific crisis can serve as a trigger for significant changes in public attitudes and opinions regarding gene editing.

communication,history & philosophy of science
Knowledge Mapping and Current Trends of Global Research on CRISPR in the Field of Cancer

Han Liu,Zongwei Lv,Gong Zhang,Xia Wang,Yuan Wang,Kefeng Wang

DOI: https://doi.org/10.3389/fcell.2023.1178221

IF: 5.5

2023-01-01

Frontiers in Cell and Developmental Biology

Abstract:Background: Gene editing tools using clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-related systems have revolutionized our understanding of cancer. The purpose of this study was to determine the distribution, collaboration, and direction of cancer research using CRISPR.Methods: Data from the Web of Science (WoS) Core Collection database were collected from 4,408 cancer publications related to CRISPR from 1 January 2013to 31 December 2022. The obtained data were analyzed using VOSviewer software for citation, co-citation, co-authorship, and co-occurrence analysis.Results: The number of annual publications has grown steadily over the past decade worldwide. The United States was shown, by far, to be the leading source of cancer publications, citations, and collaborations involving CRISPR than any other country, followed by China. Li Wei (Jilin University, China), and Harvard Medical School (Boston, MA, United States) were the author and institution with the most publications and active collaborations, respectively. The journal with the most contributions was Nature Communications (n = 147) and the journal with the most citations was Nature (n = 12,111). The research direction of oncogenic molecules, mechanisms, and cancer-related gene editing was indicated based on keyword analysis.Conclusion: The current study has provided a comprehensive overview of cancer research highlights and future trends of CRISPR, combined with a review of CRISPR applications in cancer to summarize and predict research directions and provide guidance to researchers.
Current trends of clinical trials involving CRISPR/Cas systems

Songyang Zhang,Yidi Wang,Dezhi Mao,Yue Wang,Hong Zhang,Yihan Pan,Yuezeng Wang,Shuzhi Teng,Ping Huang

DOI: https://doi.org/10.3389/fmed.2023.1292452

2023-11-10

Abstract:The CRISPR/Cas9 system is a powerful genome editing tool that has made enormous impacts on next-generation molecular diagnostics and therapeutics, especially for genetic disorders that traditional therapies cannot cure. Currently, CRISPR-based gene editing is widely applied in basic, preclinical, and clinical studies. In this review, we attempt to identify trends in clinical studies involving CRISPR techniques to gain insights into the improvement and contribution of CRISPR/Cas technologies compared to traditional modified modalities. The review of clinical trials is focused on the applications of the CRISPR/Cas systems in the treatment of cancer, hematological, endocrine, and immune system diseases, as well as in diagnostics. The scientific basis underlined is analyzed. In addition, the challenges of CRISPR application in disease therapies and recent advances that expand and improve CRISPR applications in precision medicine are discussed.

CRISPR twins: a condemnation from Chinese academic societies

Comments on the CRISPR Gene-edited Babies’ Case

Trio deep-sequencing does not reveal unexpected mutations in Cas9-edited monkeys

Breaking the germline barrier in a moral vacuum

The CRISPR-baby scandal: what’s next for human gene-editing

CCR5-Δ32 biology, gene editing, and warnings for the future of CRISPR-Cas9 as a human and humane gene editing tool

Conflict of Interest in Scientific Research in China: A Socio-ethical Analysis of He Jiankui’s Human Genome-editing Experiment

The CRISPR animal kingdom.

Debating Ethical Issues in Genome Editing Technology

[The Chinese National Twin Cohort: an Update].

Discovery in CRISPR-Cas9 system.

Development and application of CRISPR/Cas9 technologies in genomic editing.

Impact of Chromatin Organization and Epigenetics on CRISPR-Cas and TALEN Genome Editing

The Chinese National Twin Registry: a ‘gold Mine’ for Scientific Research

The application and development of CRISPR Cas9

Unexpected CRISPR off-target mutation pattern in vivo are not typically germline-like

One-step homozygosity in precise gene editing by an improved CRISPR/Cas9 system

Recent Developments in the Regulation of Heritable Human Genome Editing

Before and after the Chinese gene-edited human babies: Multiple discourses of gene editing on social media

Knowledge Mapping and Current Trends of Global Research on CRISPR in the Field of Cancer

Current trends of clinical trials involving CRISPR/Cas systems